Guided Therapeutics Inc financial data

Symbol
GTHP on OTC
Location
5835 Peachtree Corners East, Suite B, Peachtree Corners, GA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 15.8 % -37.5%
Quick Ratio 10.2 % -16.9%
Debt-to-equity -122 % +12%
Return On Assets -222 % -97.2%
Operating Margin -1.92K % +65.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 80.3M shares +42%
Common Stock, Shares, Outstanding 79K shares
Entity Public Float 3.72M USD -67.6%
Common Stock, Value, Issued 3.47M USD +0.67%
Weighted Average Number of Shares Outstanding, Basic 57K shares +10.8%
Weighted Average Number of Shares Outstanding, Diluted 68.3K shares +24.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 118K USD +211%
Research and Development Expense 457K USD +6.03%
Selling and Marketing Expense 269K USD -2.54%
General and Administrative Expense 1.62M USD +13.3%
Operating Income (Loss) -2.27M USD -6.97%
Nonoperating Income (Expense) -273K USD -435%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.54M USD -17%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.52M USD -42.1%
Earnings Per Share, Basic 0 USD/shares -25%
Earnings Per Share, Diluted 0 USD/shares -25%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 8K USD +300%
Inventory, Net 595K USD -5.85%
Other Assets, Current 23K USD -79.5%
Assets, Current 811K USD -20.6%
Property, Plant and Equipment, Net 18K USD -35.7%
Operating Lease, Right-of-Use Asset 94K USD -49.2%
Other Assets, Noncurrent 17K USD 0%
Assets 940K USD -24.9%
Accounts Payable, Current 2.26M USD +5.23%
Accrued Liabilities, Current 1.12M USD +33%
Liabilities, Current 6.38M USD +11.3%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 6.41M USD +8.35%
Retained Earnings (Accumulated Deficit) -155M USD -1.78%
Stockholders' Equity Attributable to Parent -5.47M USD -17.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -5.5M USD
Liabilities and Equity 940K USD -24.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -331K USD -231%
Net Cash Provided by (Used in) Financing Activities 58K USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 79K shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -273K USD -87%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 185K USD -32.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 20K USD +66.7%
Deferred Tax Assets, Valuation Allowance 17.6M USD -2.19%
Deferred Tax Assets, Gross 17.6M USD -2.19%
Operating Lease, Liability 104K USD -48.8%
Depreciation 2K USD 0%
Lessee, Operating Lease, Liability, to be Paid 110K USD -51.3%
Property, Plant and Equipment, Gross 1.61M USD 0%
Operating Lease, Liability, Current 104K USD +5.05%
Lessee, Operating Lease, Liability, to be Paid, Year Two 50K USD +78.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 50K USD -57.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD -73.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 50K USD -56.5%
Deferred Tax Assets, Operating Loss Carryforwards 16M USD -2.63%
Additional Paid in Capital 144M USD +1.93%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 14.8K USD -86.1%
Interest Expense 546K USD +93.6%